Global Urinary Incontinence Treatment Devices Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028
“Global Urinary Incontinence Treatment Devices Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global urinary incontinence treatment devices market report has been segmented on the basis of product, incontinence type, end user, and region.
Global Urinary Incontinence Treatment Devices Market: Overview
Urinary incontinence is defined as an involuntary loss of urine. In order to manage the urinary incontinence some form of mechanical devices that are made up of plastic or other materials are used. It is placed within the vagina or urethra for stopping or controlling the leakage of urine. Urinary incontinence may occur due to physical activity that results in increasing abdominal pressure during coughing, laughing, exercise or sneezing. Surgeries are done to prevent or decrease urine leakage via the abdomen or vagina. The treatment for urinary incontinence depends widely on the type of incontinence, its severity, the underlying cause, and age of patients.
Global Urinary Incontinence Treatment Devices Market: Dynamics
Increasing incidences of urinary tract infection is a key factor contributing to driving growth of the global market in terms of revenue over the next ten years. In addition, increasing incidences of chronic conditions such as kidney stones, neuromuscular injury, etc., development of innovative urinary catheters, rising preference for surgical treatment of urinary incontinence, and increasing per capita income level coupled with higher spending on healthcare are some of the factors driving the growth of global urinary incontinence treatment devices market. However, stringent regulatory approvals by health authorities and lack of awareness about the treatment of urinary incontinence are major factors expected to limit growth of the global market to a significant extent.
Global Urinary Incontinence Treatment Devices Market: Segment Analysis
Among the product segments, the urethral sling is expected to register the highest growth is expected to maintain its dominance over the forecast years. This is primarily due to its unique functional capabilities and is most commonly used in the surgery used to correct stress urinary incontinence (SUI). Among the incontinence type, stress urinary incontinence is expected to register the fastest growth is expected to maintain its dominance over the next 10 years. Among the end user, hospital is expected to register significant share is expected to maintain its dominance over the forthcoming.
Global Urinary Incontinence Treatment Devices Market: Trends
The key trend witnessed in the target market is manufacturers are enhancing its product offering as well as launching new technological advance products into the international market. For instance, in March 2016, Medtronic plc, which is an Ireland-based medical device company launched the NURO system device which is used for the treatment of overactive bladder.
Global Urinary Incontinence Treatment Devices Market: Regional Analysis
In 2019, the markets in North America is estimated to account for significant market revenue share in the target market, owing to increase in the higher adoption rate of technologically advanced products, as well as large medical devices companies base in countries such as Canada and US. The market in the Asia Pacific is estimated to register fastest CAGR over the forthcoming years, due to the increasing number of cases of urinary incontinence and growing elderly population in countries such as India and China in Asia Pacific region.
Segmentation by product:
- Urethral slings
- Electrical Stimulation Devices
- Artificial Urinary Sphincters
Segmentation by incontinence type:
- Stress Urinary Incontinence
- Urge Urinary Incontinence
- Mixed Incontinence
- Overflow Incontinence
Segmentation by end user:
- Ambulatory Surgery Centers
- Home Use
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2027 Revenue in US$
- Boston Scientific Corporation
- R. Bard, Inc.
- Coloplast Group
- Promedon Group
- Medtronic plc
- Ethicon US, LLC
- Incontrol Medical LLC
- Hollister Incorporated
- Atlantic Therapeutics Group Ltd.
- Braun Melsungen AG
- M.I. GmbH
- Teleflex Incorporated.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!